Akèy › Maladi Dijestif › Tennessee
Etid klinik pou Maladi Dijestif nan Tennessee
6 etid pou Maladi Dijestif ap chèche patisipan nan sit nan Tennessee.
Vil nan Tennessee
Tèks ofisyèl etid la (Anglè)
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
- Vanderbilt University Medical Center, Nashville
Ap rekriteFaz 3
Laj 18 a 90 · Tout sèks · Mizajou Sep 29, 2026 · NCT07197944Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Henry-Joyce Cancer Clinic, Nashville
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07222800Product Surveillance Registry
- Germantown
- Memphis
- Nashville
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Sep 18, 2026 · NCT01524276A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chattanooga
- 89bio Clinical Study Site, Cordova
- 89bio Clinical Study Site, Hermitage
- ak 1 plis
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 3, 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Cordova
- 89bio Clinical Study Site, Hermitage
- 89bio Clinical Study Site, Nashville
Ap rekriteFaz 3
Laj 18 a 75 · Tout sèks · Mizajou Sep 3, 2026 · NCT06419374Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).
- St. Jude Children's Research Hospital, Memphis
Ap rekriteFaz 1
Jiska laj 22 · Tout sèks · Mizajou Jul 20, 2026 · NCT05664113Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.